SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-17-004889
Filing Date
2017-05-09
Accepted
2017-05-09 07:14:34
Documents
7
Period of Report
2017-05-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 52803
2 ex4-1.htm EX-4.1 101476
3 ex5-1.htm EX-5.1 16820
4 ex10-1.htm EX-10.1 268708
5 ex5-1_001.jpg GRAPHIC 9032
6 ex5-1_003.jpg GRAPHIC 21042
7 ex5-1_002.jpg GRAPHIC 9101
  Complete submission text file 0001493152-17-004889.txt   495243
Mailing Address 1880 CENTURY PARK EAST, SUITE 1000 LOS ANGELES CA 90067
Business Address 1880 CENTURY PARK EAST, SUITE 1000 LOS ANGELES CA 90067 310-203-1000
RITTER PHARMACEUTICALS INC (Filer) CIK: 0001460702 (see all company filings)

IRS No.: 263474527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37428 | Film No.: 17824413
SIC: 2834 Pharmaceutical Preparations